Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:metformin
|
| gptkbp:approvedBy |
gptkb:FDA
2004 |
| gptkbp:ATCCode |
A10BA02
|
| gptkbp:contraindication |
metabolic acidosis
renal impairment |
| gptkbp:drugClass |
biguanide
|
| gptkbp:eliminationHalfLife |
6.2 hours
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fortamet
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Shionogi
|
| gptkbp:mechanismOfAction |
decreases hepatic glucose production
increases insulin sensitivity |
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gastrointestinal upset
lactic acidosis |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:metformin
gptkb:DB00740 gptkb:DB00783 gptkb:DB00303 gptkb:DB00170 gptkb:DB00162 |
| gptkbp:bfsLayer |
6
|